Is TXTM now ...PROTEXT PHARMA???? Anyone else notice??
Quoted from the Company profile: "To clinically prove these antidiabetic benefits in humans, Protext Pharma will undertake with Phytofare® catechins, delivered in a capsule, an independent double blind clinical study in the second quarter 2017; with the objective to commercialize an affordable solution in what is a multibillion dollar global market opportunity for the prevention and containment of metabolic syndrome causes. "
They tweeted the New Company profile at the same time as the comment about the updated financials so I decided to read it to see if I saw anything I didn't already know.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.